Point72 Middle East Fze Arrowhead Pharmaceuticals, Inc. Transaction History

Point72 Middle East Fze

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $324,460 - $446,814	-12,384 Reduced 23.99%	39,245 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $1.3 Million - $2.14 Million	51,629 New	51,629 $1.84 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $102,956 - $149,139	3,677 New	3,677 $0

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.